Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1856131rdf:typepubmed:Citationlld:pubmed
pubmed-article:1856131lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0004663lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0015733lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0031154lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0016610lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0442120lld:lifeskim
pubmed-article:1856131lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:1856131pubmed:issue4lld:pubmed
pubmed-article:1856131pubmed:dateCreated1991-8-28lld:pubmed
pubmed-article:1856131pubmed:abstractTextThe kinetics of intraperitoneal killing of proliferating bacteria was studied in pigs given fosfomycin. Eight animals were given intra-abdominal injection of Escherichia coli and Bacteroides fragilis (10(9) cfu of each species) mixed in sterile faces. Three hours later, half of the animals received an intravenous dose of 1 g fosfomycin (0.05 g/kg). Host defences rapidly decreased the density of E. coli in all animals in the first hour. After 2h, growth of E. coli started and continued throughout the experiment in pigs not receiving fosfomycin. B. fragilis was slowly eliminated in the first 5 6 h, then numbers increased in all animals. Fosfomycin caused a reduction in E. coli density, by 10(2.19) +/- 0.29 (mean +/- S.E.M.) cfu/ml, or more than 150 times within 1 h, while the concentration of B. fragilis was unaltered. After 10 h the difference in E. coli density between fosfomycin treated and untreated animals was 10(4.96) cfu/ml (P less than 0.01). Fosfomycin eradicated E. coli in faecal peritonitis but not B. fragilis, which is resistant in vitro. There was a prolonged elimination of the drug from peritoneal exudate in pigs infected with bacteria in sterile faeces compared to the elimination in uninfected pigs or pigs infected only with bacteria.lld:pubmed
pubmed-article:1856131pubmed:languageenglld:pubmed
pubmed-article:1856131pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1856131pubmed:citationSubsetIMlld:pubmed
pubmed-article:1856131pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1856131pubmed:statusMEDLINElld:pubmed
pubmed-article:1856131pubmed:monthAprlld:pubmed
pubmed-article:1856131pubmed:issn0305-7453lld:pubmed
pubmed-article:1856131pubmed:authorpubmed-author:BerglundJJlld:pubmed
pubmed-article:1856131pubmed:authorpubmed-author:AndåkerLLlld:pubmed
pubmed-article:1856131pubmed:authorpubmed-author:NyströmP OPOlld:pubmed
pubmed-article:1856131pubmed:authorpubmed-author:SkauTTlld:pubmed
pubmed-article:1856131pubmed:issnTypePrintlld:pubmed
pubmed-article:1856131pubmed:volume27lld:pubmed
pubmed-article:1856131pubmed:ownerNLMlld:pubmed
pubmed-article:1856131pubmed:authorsCompleteYlld:pubmed
pubmed-article:1856131pubmed:pagination527-33lld:pubmed
pubmed-article:1856131pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:meshHeadingpubmed-meshheading:1856131-...lld:pubmed
pubmed-article:1856131pubmed:year1991lld:pubmed
pubmed-article:1856131pubmed:articleTitleThe dynamics of intraperitoneal growth and elimination of Escherichia coli and Bacteroides fragilis in porcine faecal peritonitis treated with fosfomycin.lld:pubmed
pubmed-article:1856131pubmed:affiliationDepartment of Surgery, University Hospital, Linköping, Sweden.lld:pubmed
pubmed-article:1856131pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1856131pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed